Article Text

PDF
CASE REPORT
Acute hepatitis E superinfection leading to chronic hepatitis B reactivation
  1. Aysha Aslam,
  2. Ammu Susheela,
  3. Sentia Iriana,
  4. Suzanne S Chan,
  5. Daryl Lau
  1. Liver Center, Division of Gastroenterology, Department of, Beth Israel Deaconess Medical Center, Boston, MA, USA
  1. Correspondence to Dr Aysha Aslam, aaslam{at}bidmc.harvard.edu

Summary

Reactivation of chronic hepatitis B (CHB) can be associated with significant morbidity and mortality. There are many different causes of hepatitis B reactivation. This case describes an Asian woman with stable CHB presenting with significant hepatitis flare with markedly elevated serum aminotransferases and hepatitis B virus DNA level. The clinical symptoms were subtle with fatigue and vague right upper quadrant tenderness. We ruled out drug-associated hepatotoxicity and screened for common causes of acute hepatitis. Interestingly, she was noted to have reactive anti-hepatitis E virus (HEV) IgM at initial presentation followed by anti-HEV IgG positivity a month later. The serological pattern confirmed the diagnosis of acute hepatitis E. The combination of antiviral therapy for hepatitis B and resolution of acute hepatitis E resulted in normalisation of serum aminotransferases. This case illustrates the importance of taking a careful history and having a high index of suspicion for various aetiologies when evaluating patients with reactivation of CHB.

  • hepatitis B
  • foodborne infections
  • hepatitis other

Statistics from Altmetric.com

Footnotes

  • Contributors All authors contributed to the planning and writing the case report. AA and SI helped in writing the initial draft. SSC helped in revising the clinical vignette. AS and AA reviewed and revised the draft. DL contributed in the final revision of the manuscript. All authors approve the current draft for submission and assume responsibility for the accuracy and integrity of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.